Pediatrics · Medical Literature
[Personal View] Neonatal sepsis in Africa: what are we missing?
Abstract
Neonatal sepsis remains one of the most pressing public health challenges in Africa, threatening progress towards the UN Sustainable Development Goal target 3.2 of reducing neonatal mortality to 12 deaths or less per 1000 livebirths. Beyond the well recognised barriers to diagnosis, treatment, and prevention, additional and often overlooked determinants, including sociocultural norms, fragmented health systems, inequities in care, and low political will, continue to stall progress and sustain unacceptably high mortality rates.
Clinical relevance
Beyond well-recognized diagnostic and therapeutic barriers, what additional and underappreciated determinants — including sociocultural norms, health system fragmentation, inequities in care, antimicrobial resistance, and low political will — perpetuate unacceptably high neonatal sepsis mortality in Africa? __SNAPSHOT__ {"studyDesign":"Personal View / Expert Narrative Commentary (not an original research study; no primary data collection or hypothesis testing)","setting":"Pan-African; authors affiliated with institutions in Cameroon, South Africa, and the United Kingdom","sampleSize":"Not applicable — narrative commentary with no enrolled patient population","population":"Neonates in Africa at risk for or affected by sepsis; framed within the broader African public health and health systems context","intervention":"Conceptual identification and synthesis of overlooked determinants of neonatal sepsis mortality (sociocultural norms, health system fragmentation, care inequities, antimicrobial resistance, political will)","comparator":"Not applicable","primaryOutcome":"Not applicable — no pre-specified primary outcome; the piece argues for a broader framing of neonatal sepsis determinants in Africa beyond established clinical barriers","followUp":"Not applicable","fundingSource":"Not reported"}
Key findings
This is a Personal View article, not an interventional or observational study; therefore, no primary quantitative outcomes, effect sizes, confidence intervals, p-values, or NNTs are reported. The authors argue that neonatal sepsis remains a leading threat to achieving the UN Sustainable Development Goal target 3.2, which calls for reducing neonatal mortality to ≤12 deaths per 1,000 livebirths. In addition to widely recognized barriers to diagnosis, treatment, and prevention, the authors identify sociocultural norms, fragmented health systems, inequities in care, and low political will as critically overlooked drivers of persistent mortality. They further highlight that antimicrobial-resistant infections compound the crisis, characterizing neonatal sepsis as 'a prime example of antimicrobial resistance in Africa' in which neonates bear a disproportionate burden. No original statistical analyses, mortality estimates, or comparative data are introduced by the authors in this piece.
Practice implications
This article does not establish causal relationships, quantify effect sizes, or present new clinical trial data. It should be interpreted as an expert opinion synthesis that broadens the conceptual framework for understanding why neonatal sepsis mortality remains high across Africa despite known clinical interventions. The determinants identified — sociocultural factors (e.g., care-seeking behaviors, traditional birth practices), fragmented referral and health infrastructure, structural inequities in access to care, the growing burden of multidrug-resistant organisms, and insufficient government prioritization — are consistent with the broader published literature but are presented narratively rather than through systematic evidence synthesis. Clinicians working in African healthcare settings, global health practitioners, and policymakers will find the framing most relevant. The article does not directly address which specific populations are most vulnerable beyond the general neonatal population in Africa, and it does not provide country-specific or subgroup-level data. Practice implications are indirect: clinicians should be aware that AMR in neonatal sepsis pathogens in sub-Saharan Africa is a documented and growing threat to empirical treatment efficacy, and that community- and systems-level barriers — not only clinical factors — limit the impact of individual-level interventions. Only the abstract was available for this summary; the full article may contain additional arguments, proposed interventions, or cited evidence not captured here. __LIMITATIONS__ 1. Study design: This is a Personal View commentary, the lowest tier of evidence; it presents expert opinion without systematic literature search, inclusion/exclusion criteria, or formal evidence appraisal. 2. No primary data: No original patient-level or population-level data are presented; the framing relies on the authors' interpretation of the existing literature. 3. Selection bias in cited evidence: As a narrative commentary, citation selection may reflect the authors' perspectives rather than an exhaustive or unbiased appraisal of the literature. 4. Generalizability: 'Africa' is treated as a largely homogeneous entity; the heterogeneity in health system capacity, AMR epidemiology, sociocultural context, and political environments across 54 countries is likely underexplored. 5. Operationalizability: Structural determinants such as 'political will' and 'inequities in care' are difficult to operationalize clinically or to address through facility-based interventions alone. 6. Only the abstract was available for review; conclusions herein may not fully represent the breadth or nuance of the complete publication. __BOTTOM_LINE_CATEGORY__ low_certainty __BOTTOM_LINE__ This Lancet Microbe Personal View argues that neonatal sepsis mortality in Africa is perpetuated not only by diagnostic and therapeutic gaps, but also by sociocultural norms, fragmented health systems, inequitable access to care, antimicrobial resistance, and insufficient political will. While no new clinical data are presented, the piece provides a useful conceptual framework for clinicians and policymakers seeking to move beyond purely biomedical approaches. Clinicians practicing in or engaged with African healthcare systems should recognize AMR in neonatal pathogens as an escalating, documented threat requiring local antibiogram-guided empirical therapy and robust antimicrobial stewardship.